Association of MTHFR gene C677T mutation with diabetic peripheral neuropathy and diabetic retinopathy

Molecular Vision

Volumn 19, Issue , 2013, Pages 1626-1630

  Yigit, Serbulent ^a   Karakus, Nevin ^a   Inanir, Ahmet ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTEINE; GENOMIC DNA; THREONINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; MUTATIONAL ANALYSIS; MUTATOR GENE; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; DEMOGRAPHY; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880785161     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28:956-962. [PMID: 15793206]
2. Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS. Epidemiology, public health burden,and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007; 8:S50-S62. [PMID: 17714116]
3. Stitt AW, Lois N, Medina RJ, Adamson P, Curtis TM. Advances in our understanding of diabetic retinopathy. Clin Sci (Lond) 2013; 125:1-17. [PMID: 23485060]
4. Boulton AJ. Diabetic neuropathy: classification, measurement and treatment. Curr Opin Endocrinol Diabetes Obes 2007; 14:141-145. [PMID: 17940432]
5. Hoffmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP. Hyperhomocysteinemia and endothelial dysfunction in IDDM. Diabetes Care 1998; 20:1880-1885.
6. Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: Relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care 2000; 23:1816-1822. [PMID: 11128359]
7. Vaccaro O, Perna AF, Mancini FP, Cuomo V, Sacco M, Tufano A, Rivellese AA, Ingrosso D, Riccardi G. Plasma homocysteine and its determinants in diabetic retinopathy. Diabetes Care 2000; 23:1026-1027. [PMID: 10895864]
8. Ambrosch A, Dierkes J, Lobmann R, Kühne W, König W, Luley C, Lehnert H. Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus. Diabet Med 2001; 18:185-192. [PMID: 11318838]
9. Li JB, Cheng YZ, Shi M, Zhang HM, Dai Q, Zhang Y, Wang YJ, Chen JW, Wang HX, Chen JW. The relationship between plasma homocysteine levels and diabetic peripheral neuropathy. Zhonghua Nei Ke Za Zhi 2011; 50:14-17. [PMID: 21418881]
10. Jianbo L, Yuche C, Ming S, Jingrong T, Qing D, Yu Z, Jiawei C, Hongxing W. Association of homocysteine with peripheral neuropathy in Chinese patients with type 2 diabetes. Diabetes Res Clin Pract 2011; 93:38-42. [PMID: 21481484]
11. Toffoli G, Russo A, Innocenti F, Corona G, Tumolo S, Sartor F, Mini E, Boiocchi M. Effect of methylenetetrahydrofolate reductase 677CRT polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 2003; 103:294-299. [PMID: 12471611]
12. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-113. [PMID: 7647779]
13. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354:407-413. [PMID: 10437885]
14. Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43:414-421. [PMID: 3177384]
15. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol 1997; 34:171-177. [PMID: 9241704]
16. Seshadri N, Robinson K. Homocysteine, B vitamins and coronary artery disease. Med Clin North Am 2000; 84:215-217. [PMID: 10685136]
17. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 29:11-61.
18. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36:150-154. [PMID: 8458529]
19. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 1995; 45:1115-1121. [PMID: 7783874]
20. Schlüssel E. Homocysteine-induced oxidative damage: mechanisms and possible roles in neurodegenerative and atherogenic processes. Z Naturforsch 1995; 50:699-707. [PMID: 8579687]
21. Weir DG, Scott JM. The biochemical basis of neuropathy in cobalamin deficiency. Baillieres Clin Haematol 1995; 8:479-497. [PMID: 8534958]
22. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82:844-851. [PMID: 15640920]
23. Hoogeveen EK, Kostense PJ, Eysink PED, Polak BC, Beks PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus-the Hoorn study. Arch Intern Med 2000; 160:2984-2990. [PMID: 11041907]
24. Maeda M, Yamamoto I, Fujio Y, Azuma J. Homocysteineinduces vascular endothelial growth factor expression in differentiated THP-1 macrophages. Biochim Biophys Acta 2003; 1623:41-46. [PMID: 12957716]
25. Roybal CN, Yang S, Sun CW, Hurtado D, Vander Jagt DL, Townes TM, Abcouwer SF. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem 2004; 279:14844-14852. [PMID: 14747470]
26. Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004; 53:861-864. [PMID: 14988276]
27. Niu W, Qi Y. An updated meta-analysis of methylenetetrahydrofolate reductase gene 677C/T polymorphism with diabetic nephropathy and diabetic retinopathy. Diabetes Res Clin Pract 2012; 95:110-118. [PMID: 22056717]